Stay updated with breaking news from Seth Lederman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Tonix Pharmaceuticals (NASDAQ:TNXP) CEO Seth Lederman joined Proactive's Stephen Gunnion with news that the company has a monkeypox vaccine in development....
Our experience with COVID-19 has shown that you can’t reach herd immunity if you can’t block forward transmission. To interrupt the surge...
01.08.2022 - New patent expected to expire in 2036 Phase 2 Study for Prevention of Migraine Headache Expected to Start Second Half 2022 CHATHAM, N.J., Aug. 01, 2022 (GLOBE NEWSWIRE) - Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage ... Seite 1
Phase 1 Clinical Study Expected to be Initiated in Kenya in the First Half of 2023 World Health Organization Has Declared Monkeypox a Global Health...
CHATHAM, N.J., July 25, 2022 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage...